Insmed Inc (INSM)
24.92
-0.89
(-3.45%)
USD |
NASDAQ |
Apr 25, 16:00
24.91
-0.01
(-0.04%)
After-Hours: 20:00
Insmed Total Liabilities (Quarterly): 1.662B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.662B |
| September 30, 2023 | 1.614B |
| June 30, 2023 | 1.595B |
| March 31, 2023 | 1.562B |
| December 31, 2022 | 1.568B |
| September 30, 2022 | 1.025B |
| June 30, 2022 | 1.009B |
| March 31, 2022 | 1.033B |
| December 31, 2021 | 833.04M |
| September 30, 2021 | 806.93M |
| June 30, 2021 | 698.73M |
| March 31, 2021 | 490.76M |
| December 31, 2020 | 520.27M |
| September 30, 2020 | 483.65M |
| June 30, 2020 | 480.05M |
| March 31, 2020 | 469.82M |
| December 31, 2019 | 480.62M |
| September 30, 2019 | 459.08M |
| June 30, 2019 | 446.21M |
| March 31, 2019 | 451.78M |
| December 31, 2018 | 396.29M |
| September 30, 2018 | 370.11M |
| June 30, 2018 | 353.60M |
| March 31, 2018 | 338.30M |
| December 31, 2017 | 100.99M |
| Date | Value |
|---|---|
| September 30, 2017 | 84.90M |
| June 30, 2017 | 82.20M |
| March 31, 2017 | 78.98M |
| December 31, 2016 | 83.47M |
| September 30, 2016 | 58.82M |
| June 30, 2016 | 49.12M |
| March 31, 2016 | 45.24M |
| December 31, 2015 | 44.86M |
| September 30, 2015 | 46.74M |
| June 30, 2015 | 43.17M |
| March 31, 2015 | 41.29M |
| December 31, 2014 | 44.63M |
| September 30, 2014 | 36.18M |
| June 30, 2014 | 38.56M |
| March 31, 2014 | 34.88M |
| December 31, 2013 | 33.17M |
| September 30, 2013 | 32.82M |
| June 30, 2013 | 33.54M |
| March 31, 2013 | 35.41M |
| December 31, 2012 | 32.68M |
| September 30, 2012 | 15.84M |
| June 30, 2012 | 16.34M |
| March 31, 2012 | 5.119M |
| December 31, 2011 | 5.566M |
| September 30, 2011 | 3.727M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
446.21M
Minimum
Jun 2019
1.662B
Maximum
Dec 2023
907.27M
Average
806.93M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| NeuroMetrix Inc | 1.333M |
| Intra-Cellular Therapies Inc | 136.87M |
| Rhythm Pharmaceuticals Inc | 162.99M |
| Amylyx Pharmaceuticals Inc | 84.02M |
| AN2 Therapeutics Inc | 14.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.330B |
| Shareholders Equity (Quarterly) | -331.92M |
| Debt to Equity Ratio | -3.481 |
| Current Ratio | 4.118 |
| Net Debt Paydown Yield | -1.62% |